3P Biopharmaceuticals was founded in 2007 and it is based in Pamplona, a city located in the north of Spain.
We are a leading European CDMO specialized in process development and cGMP manufacturing of biologics, and cell therapy products using microbial and mammalian expressions systems.
As a One Stop Shop, we offer solutions at all stages of biologics development, from initial process and analytics development to preclinical and clinical phases and commercial production.
We focus on biotechnology applied to the health sector and we offer process development and manufacturing services for biological drugs.
WHAT WE DO: solutions for your biologics
CORE VALUES: OUR 3PS
We are a preferred global partner for pharmaceutical and biotech companies.
Our clients are involved in developing drugs that treat various diseases and improve the lives of many people. We take pride in collaborating to create innovative therapeutics that can change the lives of patients.
At 3P Biopharmaceuticals, we firmly believe in working hand in hand with our customers. We are committed to a constant focus on excellence in order to ensure the success of our customers´ projects.
As a reliable partner, we strive to create close and long-term relationships to efficiently advance the development of healthcare solutions. As each project, each molecule, and each client is different, so we are flexible to develop the perfect technology that is tailored to the specific needs of our customers.
3P represents a robust outsourcing partner along the entire drug development life cycle through our key capabilities:
We combine technological innovation with manufacturing and process excellence.
We combine People, Passion and Precision to define our core values at 3P.
Keensight Capital, one of the leading European Growth Buyout firms, is committed to supporting entrepreneurs as they implement their growth strategies. For 20 years, Keensight Capital’s team of seasoned professionals has leveraged their knowledge of investment and growth industries to invest for the long term in profitable companies with high growth potential and revenues in the range of €15 million to €250 million.
Drawing on its expertise in the Information Technology/Internet and Healthcare/Wellbeing sectors, Keensight identifies the best investment opportunities in Europe and works closely with management teams to develop and achieve their strategic vision.